RATIONALE: Endothelial dysfunction inflicted by inflammation is found in a host of cardiovascular pathologies. One hallmark event in this process is the aggregation and adhesion of leukocyte to the vessel wall mediated by the upregulation of adhesion molecules (CAM) in endothelial cells at the transcriptional level. The epigenetic modulator(s) of CAM transactivation and its underlying pathophysiological relevance remain poorly defined. OBJECTIVE: Our goal was to determine the involvement of Brahma related gene 1 (Brg1) and Brahma (Brm) in CAM transactivation and its relevance in the pathogenesis of atherosclerosis. METHODS AND RESULTS: In the present study, we report that proinflammatory stimuli augmented the expression of Brg1 and Brm in vitro in cultured endothelial cells and in vivo in arteries isolated from rodents. Overexpression of Brg1 and Brm promoted while knockdown of Brg1 and Brm abrogated transactivation of adhesion molecules and leukocyte adhesion induced by inflammatory signals. Brg1 and Brm interacted with and were recruited to the CAM promoters by nuclear factor κB/p65. Conversely, depletion of Brg1 and Brm disrupted the kinetics of p65 binding on CAM promoters and crippled CAM activation. Silencing of Brg1 and Brm also altered key epigenetic changes associated with CAM transactivation. Of intrigue, 17β-estradiol antagonized both the expression and activity of Brg1/Brm. Most importantly, endothelial-targeted elimination of Brg1/Brm conferred atheroprotective effects to Apoe(-/-) mice on a Western diet. CONCLUSIONS: Our data suggest that Brg1 and Brm integrate various proinflammatory cues into CAM transactivation and endothelial malfunction and, as such, may serve as potential therapeutic targets in treating inflammation-related cardiovascular diseases.
RATIONALE: Endothelial dysfunction inflicted by inflammation is found in a host of cardiovascular pathologies. One hallmark event in this process is the aggregation and adhesion of leukocyte to the vessel wall mediated by the upregulation of adhesion molecules (CAM) in endothelial cells at the transcriptional level. The epigenetic modulator(s) of CAM transactivation and its underlying pathophysiological relevance remain poorly defined. OBJECTIVE: Our goal was to determine the involvement of Brahma related gene 1 (Brg1) and Brahma (Brm) in CAM transactivation and its relevance in the pathogenesis of atherosclerosis. METHODS AND RESULTS: In the present study, we report that proinflammatory stimuli augmented the expression of Brg1 and Brm in vitro in cultured endothelial cells and in vivo in arteries isolated from rodents. Overexpression of Brg1 and Brm promoted while knockdown of Brg1 and Brm abrogated transactivation of adhesion molecules and leukocyte adhesion induced by inflammatory signals. Brg1 and Brm interacted with and were recruited to the CAM promoters by nuclear factor κB/p65. Conversely, depletion of Brg1 and Brm disrupted the kinetics of p65 binding on CAM promoters and crippled CAM activation. Silencing of Brg1 and Brm also altered key epigenetic changes associated with CAM transactivation. Of intrigue, 17β-estradiol antagonized both the expression and activity of Brg1/Brm. Most importantly, endothelial-targeted elimination of Brg1/Brm conferred atheroprotective effects to Apoe(-/-) mice on a Western diet. CONCLUSIONS: Our data suggest that Brg1 and Brm integrate various proinflammatory cues into CAM transactivation and endothelial malfunction and, as such, may serve as potential therapeutic targets in treating inflammation-related cardiovascular diseases.
Authors: Min Zhang; Meng Chen; Ju-Ryoung Kim; Jiliang Zhou; Rebekah E Jones; Johnathan D Tune; Ghassan S Kassab; Daniel Metzger; Shawn Ahlfeld; Simon J Conway; B Paul Herring Journal: Mol Cell Biol Date: 2011-04-25 Impact factor: 4.272
Authors: Courtney T Griffin; Carol D Curtis; Reema B Davis; Vijay Muthukumar; Terry Magnuson Journal: Proc Natl Acad Sci U S A Date: 2011-01-24 Impact factor: 11.205
Authors: Bradley D Gelfand; Julia Meller; Andrew W Pryor; Michael Kahn; Pamela D Schoppee Bortz; Brian R Wamhoff; Brett R Blackman Journal: Arterioscler Thromb Vasc Biol Date: 2011-04-28 Impact factor: 8.311
Authors: Jason E Fish; Matthew S Yan; Charles C Matouk; Rosanne St Bernard; J J David Ho; J J David Ho; Anna Gavryushova; Deepak Srivastava; Philip A Marsden Journal: J Biol Chem Date: 2009-10-30 Impact factor: 5.157
Authors: Aikaterini Tsaousi; Helen Williams; Cressida A Lyon; Victoria Taylor; Amanda Swain; Jason L Johnson; Sarah J George Journal: Circ Res Date: 2010-12-30 Impact factor: 17.367
Authors: Colleen G Julian; Brent S Pedersen; Carlos Salinas Salmon; Ivana V Yang; Marcelino Gonzales; Enrique Vargas; Lorna G Moore; David A Schwartz Journal: Clin Transl Sci Date: 2015-11-06 Impact factor: 4.689